Of particular interest in the field is the role of heparanase in myeloma because its overexpression in the bone marrow environment was associated with a shorter event-free survival of patients with newly diagnosed myeloma treated with high-dose chemotherapy and stem cell transplantation (52). The gene discussed is HPSE; the disease is plasma cell myeloma.